Giorgio Treglia

Jan 3, 2025 | mdpi.com | Giorgio Treglia

Open AccessInteresting Images by Cesare Michele Iacovitti 1, Barbara Muoio 2, Marco Cuzzocrea 1, Gaetano Paone 1,3 and Giorgio Treglia 1,3,4,* 1 Division of Nuclear Medicine, Imaging Institute of Southern Switzerland, Ente Ospedaliero Cantonale, 6500 Bellinzona, Switzerland 2 Division of Medical Oncology, Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, 6500 Bellinzona, Switzerland 3 Faculty of Biomedical Sciences, Università della Svizzera Italiana, 6900 Lugano,...

Jul 25, 2024 | mdpi.com | Giorgio Treglia |Domenico Albano |Alessio Rizzo |Antonio Bellasi

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

Nov 6, 2023 | frontiersin.org | Giorgio Treglia

Copper-64 in cancer Copper-64 decays through the emission of positrons and a cascade of low-energy Meitner-Auger electrons. Therefore, it can be used for both positron emission tomography (PET) imaging and cancer therapy by taking advantage of the high linear-energy-transfer of Meitner-Auger electrons.

Aug 25, 2023 | frontiersin.org | Spedali Civili |Reggio Emilia |Giorgio Treglia

Hybrid imaging, namely, the fusion of different imaging techniques in a single technology, and combined imaging, e.g., the merging of information derived from different imaging techniques, are increasingly used for disease diagnosis, characterization, and prognosis prediction.

May 30, 2023 | frontiersin.org | Giorgio Treglia

The world of medicine is continuously evolving, constantly seeking novel and more effective diagnostic and therapeutic methods. One of the most promising advancements in recent years is the development of ImmunoPET imaging—a powerful tool that harnesses the specificity of antibodies and the sensitivity of positron emission tomography (PET) to visualize and quantify biomarkers in vivo.